A quarter-century of antiviral therapy

Nonviral interferon inducers.

The Journal of general physiology·2009

Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946).

AIDS research and human retroviruses·2001

Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients.

Journal of virology·2001

Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogs.

Antimicrobial agents and chemotherapy·2001

High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.

Journal of clinical microbiology·2001

Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.

AIDS research and human retroviruses·2001

Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

The New England journal of medicine·2026

Tozorakimab to Prevent COPD Exacerbations.

The New England journal of medicine·2026

A Response to Dimaggio et al.'s Commentary on Mohajerin et al. (2026).

Clinical psychology & psychotherapy·2026

Reviewer #2 and other natural disasters: Humorous reflections on the Peer Review process.

American journal of surgery·2026

Already Counter-Inductive: Feyerabend, Phenomenologically Inspired Methods, and the Unrealized Epistemological Potential of Qualitative Health Research.

Qualitative health research·2026

The Trickster Turn: Decolonial Epistemology for AI in Leadership Education.

New directions for student leadership·2026

Raven's Matrices: What do They Really Measure? Implications for Clinical Practice and Diagnosis.

Psychological reports·2026

Distinct characteristics and risk factors of symptomatic and incidental DWI lesions in cerebral amyloid angiopathy.

Journal of neurology·2026

Related Experiment Videos

A quarter-century of antiviral therapy

Related Concept Videos

Nonviral interferon inducers.

Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946).

Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients.

Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogs.

High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.

Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.

Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

Tozorakimab to Prevent COPD Exacerbations.

A Response to Dimaggio et al.'s Commentary on Mohajerin et al. (2026).

Reviewer #2 and other natural disasters: Humorous reflections on the Peer Review process.

Already Counter-Inductive: Feyerabend, Phenomenologically Inspired Methods, and the Unrealized Epistemological Potential of Qualitative Health Research.

The Trickster Turn: Decolonial Epistemology for AI in Leadership Education.

Raven's Matrices: What do They Really Measure? Implications for Clinical Practice and Diagnosis.

Distinct characteristics and risk factors of symptomatic and incidental DWI lesions in cerebral amyloid angiopathy.

Related Experiment Videos

A quarter-century of antiviral therapy

Related Concept Videos

Related Articles